Progyny, Inc. (PGNY) stock analysis
In our weekly check, Progyny, Inc. is graded B (A to F). Of 23 checks on debt, profit, cash flow and trend: 17 pass, warnings: 2, red flags: 4.
About Progyny, Inc.
Progyny, Inc. is a Healthcare company (Health Information Services) based in the United States, listed on NASDAQ as PGNY.
What our checks show for PGNY
Red flags
- The net margin fell by 6.3 points over 5 years, to 6.8%: the company keeps less of each sale as profit.
- The price swings a lot: 50.6% annual volatility. Expect large ups and downs.
- The stock has fallen as much as 79% from a peak. Would you have held through that?
- Pay in shares equals 52.8% of free cash flow: it dilutes shareholders.
Warning signs
- The net margin is only 6.8%: little room if costs rise.
- The stock is still below its previous peak.
Strengths
- Debt is low: 0.05x equity.
- The gross margin is 24.9% and has risen by 2.5 points: pricing power is holding.
- Operating cash flow is 2.78x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 23.5% a year over the next years.
- Analysts expect the net margin to improve by 3.1 points from today's 6.8%.
- Revenue grew 19.4% a year over the last 3 years.
Similar companies
CLOV · ALHC · OSCR · MOH
Questions
What grade does Progyny, Inc. (PGNY) have?
In our weekly check, Progyny, Inc. is graded B (A to F). Of 23 checks on debt, profit, cash flow and trend: 17 pass, warnings: 2, red flags: 4. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of PGNY stock?
This week's biggest flags for Progyny, Inc.: Margins falling, Very volatile, Deep past fall. In total 6 of 23 checks show a warning or a red flag.
What does Progyny, Inc. do?
Progyny, Inc. is a Healthcare company (Health Information Services) based in the United States, listed on NASDAQ as PGNY.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis